Revvity (RVTY) Net Income towards Common Stockholders (2009 - 2026)
Revvity's (RVTY) quarterly Net Income towards Common Stockholders came in at -$175000.0 in Q2 2026, down 130.81% YoY from $568000.0 in Q2 2025, and down 106.75% on a QoQ basis from $2.6 million in Q4 2025.
Revvity (RVTY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$175000.0 in Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 130.81% year-over-year to -$175000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $575000.0 (up 106.09% YoY) and the FY2025 annual result came in at $1.3 million, up 110.39% from the prior year.
- Net Income towards Common Stockholders fell to -$175000.0 in Q2 2026, from $2.6 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $544.6 million in Q2 2023 to a low of -$23.1 million in Q3 2023.
- A 5-year average of $32.3 million and a median of $568000.0 in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders surged 8449.32% — and 2023, when it sank 245.03%.
- Tracing RVTY's Net Income towards Common Stockholders over 5 years: stood at $15.8 million in 2022, then slumped by 245.03% to -$23.0 million in 2023, then jumped by 127.26% to $6.3 million in 2024, then tumbled by 58.59% to $2.6 million in 2025, then slumped by 106.75% to -$175000.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$175000.0 (Q2 2026), $2.6 million (Q4 2025), and -$569000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -175,000.00 |
| Dec 28, 2025 | 2.59 Mn |
| Sep 28, 2025 | -569,000.00 |
| Jun 29, 2025 | -1.27 Mn |
| Mar 30, 2025 | 568,000.00 |
| Dec 29, 2024 | 6.26 Mn |
| Sep 29, 2024 | 981,000.00 |
| Jun 30, 2024 | -17.25 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Oct 1, 2023 | -22.97 Mn |
| Jul 2, 2023 | -23.06 Mn |
| Apr 2, 2023 | 544.63 Mn |
| Jan 1, 2023 | 30.16 Mn |
| Oct 2, 2022 | 15.84 Mn |
| Jul 3, 2022 | 17.61 Mn |
| Apr 3, 2022 | -7.11 Mn |
| Jan 2, 2022 | 6.10 Mn |
| Oct 3, 2021 | 20.11 Mn |
| Jul 4, 2021 | 18.07 Mn |
| Apr 4, 2021 | 9.45 Mn |